This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farina, S. F.
Right arrow Articles by Wilson, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farina, S. F.
Right arrow Articles by Wilson, J. M.

 Previous Article  |  Next Article 

Journal of Virology, December 2001, p. 11603-11613, Vol. 75, No. 23
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.23.11603-11613.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Replication-Defective Vector Based on a Chimpanzee Adenovirus

Steven F. Farina,1 Guang-ping Gao,1 Z. Q. Xiang,2 John J. Rux,2 Roger M. Burnett,2 Mauricio R. Alvira,1 Jonathan Marsh,1 Hildegund C. J. Ertl,2 and James M. Wilson1,2,*

Institute for Human Gene Therapy and Department of Molecular and Cellular Engineering, University of Pennsylvania,1 and The Wistar Institute,2 Philadelphia, Pennsylvania

Received 21 June 2001/Accepted 30 August 2001

An adenovirus previously isolated from a mesenteric lymph node from a chimpanzee was fully sequenced and found to be similar in overall structure to human adenoviruses. The genome of this virus, called C68, is 36,521 bp in length and is most similar to subgroup E of human adenovirus, with 90% identity in most adenovirus type 4 open reading frames that have been sequenced. Substantial differences in the hexon hypervariable regions were noted between C68 and other known adenoviruses, including adenovirus type 4. Neutralizing antibodies to C68 were highly prevalent in sera from a population of chimpanzees, while sera from humans and rhesus monkeys failed to neutralize C68. Furthermore, infection with C68 was not neutralized from sera of mice immunized with human adenovirus serotypes 2, 4, 5, 7, and 12. A replication-defective version of C68 was created by replacing the E1a and E1b genes with a minigene cassette; this vector was efficiently transcomplemented by the E1 region of human adenovirus type 5. C68 vector transduced a number of human and murine cell lines. This nonhuman adenoviral vector is sufficiently similar to human serotypes to allow growth in 293 cells and transduction of cells expressing the coxsackievirus and adenovirus receptor. As it is dissimilar in regions such as the hexon hypervariable domains, C68 vector avoids significant cross-neutralization by sera directed against human serotypes.

* Corresponding author. Mailing address: 204 Wistar Institute, 3601 Spruce St., Philadelphia, PA 19104-4268. Phone: (215-) 898-3000. Fax: (215) 898-6588. E-mail: wilsonjm{at}mail.med.upenn.edu.

Journal of Virology, December 2001, p. 11603-11613, Vol. 75, No. 23
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.23.11603-11613.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Haut, L. H., Ertl, H. C. J. (2009). Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine. J. Leukoc. Biol. 86: 779-793 [Abstract] [Full Text]  
  • Tatsis, N., Lasaro, M. O., Lin, S.-W., Xiang, Z. Q., Zhou, D., DiMenna, L., Li, H., Bian, A., Abdulla, S., Li, Y., Giles-Davis, W., Engram, J., Ratcliffe, S. J., Silvestri, G., Ertl, H. C., Betts, M. R. (2009). Adenovirus Vector-Induced Immune Responses in Nonhuman Primates: Responses to Prime Boost Regimens. J. Immunol. 182: 6587-6599 [Abstract] [Full Text]  
  • Schoenly, K. A., Weiner, D. B. (2008). Human Immunodeficiency Virus Type 1 Vaccine Development: Recent Advances in the Cytotoxic T-Lymphocyte Platform "Spotty Business". J. Virol. 82: 3166-3180 [Full Text]  
  • Sakurai, H., Tashiro, K., Kawabata, K., Yamaguchi, T., Sakurai, F., Nakagawa, S., Mizuguchi, H. (2008). Adenoviral Expression of Suppressor of Cytokine Signaling-1 Reduces Adenovirus Vector-Induced Innate Immune Responses. J. Immunol. 180: 4931-4938 [Abstract] [Full Text]  
  • Stahl-Hennig, C., Kuate, S., Franz, M., Suh, Y. S., Stoiber, H., Sauermann, U., Tenner-Racz, K., Norley, S., Park, K. S., Sung, Y. C., Steinman, R., Racz, P., Uberla, K. (2007). Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines. J. Virol. 81: 13180-13190 [Abstract] [Full Text]  
  • Lin, J., Zhi, Y., Mays, L., Wilson, J. M. (2007). Vaccines Based on Novel Adeno-Associated Virus Vectors Elicit Aberrant CD8+ T-Cell Responses in Mice. J. Virol. 81: 11840-11849 [Abstract] [Full Text]  
  • Santra, S., Sun, Y., Parvani, J. G., Philippon, V., Wyand, M. S., Manson, K., Gomez-Yafal, A., Mazzara, G., Panicali, D., Markham, P. D., Montefiori, D. C., Letvin, N. L. (2007). Heterologous Prime/Boost Immunization of Rhesus Monkeys by Using Diverse Poxvirus Vectors. J. Virol. 81: 8563-8570 [Abstract] [Full Text]  
  • Madisch, I., Hofmayer, S., Moritz, C., Grintzalis, A., Hainmueller, J., Pring-Akerblom, P., Heim, A. (2007). Phylogenetic Analysis and Structural Predictions of Human Adenovirus Penton Proteins as a Basis for Tissue-Specific Adenovirus Vector Design. J. Virol. 81: 8270-8281 [Abstract] [Full Text]  
  • Abbink, P., Lemckert, A. A. C., Ewald, B. A., Lynch, D. M., Denholtz, M., Smits, S., Holterman, L., Damen, I., Vogels, R., Thorner, A. R., O'Brien, K. L., Carville, A., Mansfield, K. G., Goudsmit, J., Havenga, M. J. E., Barouch, D. H. (2007). Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D. J. Virol. 81: 4654-4663 [Abstract] [Full Text]  
  • Pichla-Gollon, S. L., Drinker, M., Zhou, X., Xue, F., Rux, J. J., Gao, G.-P., Wilson, J. M., Ertl, H. C. J., Burnett, R. M., Bergelson, J. M. (2007). Structure-Based Identification of a Major Neutralizing Site in an Adenovirus Hexon. J. Virol. 81: 1680-1689 [Abstract] [Full Text]  
  • Koizumi, N., Yamaguchi, T., Kawabata, K., Sakurai, F., Sasaki, T., Watanabe, Y., Hayakawa, T., Mizuguchi, H. (2007). Fiber-Modified Adenovirus Vectors Decrease Liver Toxicity through Reduced IL-6 Production. J. Immunol. 178: 1767-1773 [Abstract] [Full Text]  
  • Hanke, T., McMichael, A. J., Dorrell, L. (2007). Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction. J. Gen. Virol. 88: 1-12 [Abstract] [Full Text]  
  • Thorner, A. R., Lemckert, A. A. C., Goudsmit, J., Lynch, D. M., Ewald, B. A., Denholtz, M., Havenga, M. J. E., Barouch, D. H. (2006). Immunogenicity of Heterologous Recombinant Adenovirus Prime-Boost Vaccine Regimens Is Enhanced by Circumventing Vector Cross-Reactivity. J. Virol. 80: 12009-12016 [Abstract] [Full Text]  
  • Thorner, A. R., Vogels, R., Kaspers, J., Weverling, G. J., Holterman, L., Lemckert, A. A. C., Dilraj, A., McNally, L. M., Jeena, P. M., Jepsen, S., Abbink, P., Nanda, A., Swanson, P. E., Bates, A. T., O'Brien, K. L., Havenga, M. J. E., Goudsmit, J., Barouch, D. H. (2006). Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-saharan Africa.. J. Clin. Microbiol. 44: 3781-3783 [Abstract] [Full Text]  
  • Roy, S., Zhi, Y., Kobinger, G. P., Figueredo, J., Calcedo, R., Miller, J. R., Feldmann, H., Wilson, J. M. (2006). Generation of an adenoviral vaccine vector based on simian adenovirus 21. J. Gen. Virol. 87: 2477-2485 [Abstract] [Full Text]  
  • Ruzsics, Z., Wagner, M., Osterlehner, A., Cook, J., Koszinowski, U., Burgert, H.-G. (2006). Transposon-assisted cloning and traceless mutagenesis of adenoviruses: development of a novel vector based on species d.. J. Virol. 80: 8100-8113 [Abstract] [Full Text]  
  • Gao, W., Soloff, A. C., Lu, X., Montecalvo, A., Nguyen, D. C., Matsuoka, Y., Robbins, P. D., Swayne, D. E., Donis, R. O., Katz, J. M., Barratt-Boyes, S. M., Gambotto, A. (2006). Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization. J. Virol. 80: 1959-1964 [Abstract] [Full Text]  
  • Barratt-Boyes, S. M., Soloff, A. C., Gao, W., Nwanegbo, E., Liu, X., Rajakumar, P. A., Brown, K. N., Robbins, P. D., Murphey-Corb, M., Day, R. D., Gambotto, A. (2006). Broad cellular immunity with robust memory responses to simian immunodeficiency virus following serial vaccination with adenovirus 5- and 35-based vectors. J. Gen. Virol. 87: 139-149 [Abstract] [Full Text]  
  • Hensley, S. E., Giles-Davis, W., McCoy, K. C., Weninger, W., Ertl, H. C. J. (2005). Dendritic Cell Maturation, but Not CD8+ T Cell Induction, Is Dependent on Type I IFN Signaling during Vaccination with Adenovirus Vectors. J. Immunol. 175: 6032-6041 [Abstract] [Full Text]  
  • Hashimoto, M., Boyer, J. L., Hackett, N. R., Wilson, J. M., Crystal, R. G. (2005). Induction of Protective Immunity to Anthrax Lethal Toxin with a Nonhuman Primate Adenovirus-Based Vaccine in the Presence of Preexisting Anti-Human Adenovirus Immunity. Infect. Immun. 73: 6885-6891 [Abstract] [Full Text]  
  • Peng, B., Wang, L. R., Gomez-Roman, V. R., Davis-Warren, A., Montefiori, D. C., Kalyanaraman, V. S., Venzon, D., Zhao, J., Kan, E., Rowell, T. J., Murthy, K. K., Srivastava, I., Barnett, S. W., Robert-Guroff, M. (2005). Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies. J. Virol. 79: 10200-10209 [Abstract] [Full Text]  
  • Lemckert, A. A. C., Sumida, S. M., Holterman, L., Vogels, R., Truitt, D. M., Lynch, D. M., Nanda, A., Ewald, B. A., Gorgone, D. A., Lifton, M. A., Goudsmit, J., Havenga, M. J. E., Barouch, D. H. (2005). Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity. J. Virol. 79: 9694-9701 [Abstract] [Full Text]  
  • Kovacs, G. M., Harrach, B., Zakhartchouk, A. N., Davison, A. J. (2005). Complete genome sequence of simian adenovirus 1: an Old World monkey adenovirus with two fiber genes. J. Gen. Virol. 86: 1681-1686 [Abstract] [Full Text]  
  • Sumida, S. M., Truitt, D. M., Lemckert, A. A. C., Vogels, R., Custers, J. H. H. V., Addo, M. M., Lockman, S., Peter, T., Peyerl, F. W., Kishko, M. G., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Essex, M., Walker, B. D., Goudsmit, J., Havenga, M. J. E., Barouch, D. H. (2005). Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein. J. Immunol. 174: 7179-7185 [Abstract] [Full Text]  
  • Purkayastha, A., Ditty, S. E., Su, J., McGraw, J., Hadfield, T. L., Tibbetts, C., Seto, D. (2005). Genomic and Bioinformatics Analysis of HAdV-4, a Human Adenovirus Causing Acute Respiratory Disease: Implications for Gene Therapy and Vaccine Vector Development. J. Virol. 79: 2559-2572 [Abstract] [Full Text]  
  • Jacobs, S. C., Davison, A. J., Carr, S., Bennett, A. M., Phillpotts, R., Wilkinson, G. W. G. (2004). Characterization and manipulation of the human adenovirus 4 genome. J. Gen. Virol. 85: 3361-3366 [Abstract] [Full Text]  
  • Kovacs, G. M., Davison, A. J., Zakhartchouk, A. N., Harrach, B. (2004). Analysis of the first complete genome sequence of an Old World monkey adenovirus reveals a lineage distinct from the six human adenovirus species. J. Gen. Virol. 85: 2799-2807 [Abstract] [Full Text]  
  • Reyes-Sandoval, A., Fitzgerald, J. C., Grant, R., Roy, S., Xiang, Z. Q., Li, Y., Gao, G. P., Wilson, J. M., Ertl, H. C. J. (2004). Human Immunodeficiency Virus Type 1-Specific Immune Responses in Primates upon Sequential Immunization with Adenoviral Vaccine Carriers of Human and Simian Serotypes. J. Virol. 78: 7392-7399 [Abstract] [Full Text]  
  • Barouch, D. H., Pau, M. G., Custers, J. H. H. V., Koudstaal, W., Kostense, S., Havenga, M. J. E., Truitt, D. M., Sumida, S. M., Kishko, M. G., Arthur, J. C., Korioth-Schmitz, B., Newberg, M. H., Gorgone, D. A., Lifton, M. A., Panicali, D. L., Nabel, G. J., Letvin, N. L., Goudsmit, J. (2004). Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity. J. Immunol. 172: 6290-6297 [Abstract] [Full Text]  
  • Giri, M., Ugen, K. E., Weiner, D. B. (2004). DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade. Clin. Microbiol. Rev. 17: 370-389 [Abstract] [Full Text]  
  • Sumida, S. M., Truitt, D. M., Kishko, M. G., Arthur, J. C., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Koudstaal, W., Pau, M. G., Kostense, S., Havenga, M. J. E., Goudsmit, J., Letvin, N. L., Barouch, D. H. (2004). Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors. J. Virol. 78: 2666-2673 [Abstract] [Full Text]  
  • Barzon, L., Boscaro, M., Palu, G. (2004). Endocrine Aspects of Cancer Gene Therapy. Endocr. Rev. 25: 1-44 [Abstract] [Full Text]  
  • Pinto, A. R., Fitzgerald, J. C., Giles-Davis, W., Gao, G. P., Wilson, J. M., Ertl, H. C. J. (2003). Induction of CD8+ T Cells to an HIV-1 Antigen through a Prime Boost Regimen with Heterologous E1-Deleted Adenoviral Vaccine Carriers. J. Immunol. 171: 6774-6779 [Abstract] [Full Text]  
  • Davison, A. J., Benko, M., Harrach, B. (2003). Genetic content and evolution of adenoviruses. J. Gen. Virol. 84: 2895-2908 [Abstract] [Full Text]  
  • Xiang, Z. Q., Gao, G. P., Reyes-Sandoval, A., Li, Y., Wilson, J. M., Ertl, H. C. J. (2003). Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier. J. Virol. 77: 10780-10789 [Abstract] [Full Text]  
  • Xiang, Z., Li, Y., Gao, G., Wilson, J. M., Ertl, H. C. J. (2003). Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice. J. Immunol. 171: 4287-4293 [Abstract] [Full Text]  
  • Rux, J. J., Kuser, P. R., Burnett, R. M. (2003). Structural and Phylogenetic Analysis of Adenovirus Hexons by Use of High-Resolution X-Ray Crystallographic, Molecular Modeling, and Sequence-Based Methods. J. Virol. 77: 9553-9566 [Abstract] [Full Text]  
  • Vogels, R., Zuijdgeest, D., van Rijnsoever, R., Hartkoorn, E., Damen, I., de Bethune, M.-P., Kostense, S., Penders, G., Helmus, N., Koudstaal, W., Cecchini, M., Wetterwald, A., Sprangers, M., Lemckert, A., Ophorst, O., Koel, B., van Meerendonk, M., Quax, P., Panitti, L., Grimbergen, J., Bout, A., Goudsmit, J., Havenga, M. (2003). Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity. J. Virol. 77: 8263-8271 [Abstract] [Full Text]  
  • Fitzgerald, J. C., Gao, G.-P., Reyes-Sandoval, A., Pavlakis, G. N., Xiang, Z. Q., Wlazlo, A. P., Giles-Davis, W., Wilson, J. M., Ertl, H. C. J. (2003). A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag. J. Immunol. 170: 1416-1422 [Abstract] [Full Text]  
  • Vinner, L., Wee, E. G.-T., Patel, S., Corbet, S., Gao, G. P., Nielsen, C., Wilson, J. M., Ertl, H. C. J., Hanke, T., Fomsgaard, A. (2003). Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost. J. Gen. Virol. 84: 203-213 [Abstract] [Full Text]  
  • Yang, Z.-y., Wyatt, L. S., Kong, W.-p., Moodie, Z., Moss, B., Nabel, G. J. (2002). Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting. J. Virol. 77: 799-803 [Abstract] [Full Text]  
  • Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., Wilson, J. M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99: 11854-11859 [Abstract] [Full Text]  
  • Varnavski, A. N., Zhang, Y., Schnell, M., Tazelaar, J., Louboutin, J.-P., Yu, Q.-C., Bagg, A., Gao, G.-p., Wilson, J. M. (2002). Preexisting Immunity to Adenovirus in Rhesus Monkeys Fails To Prevent Vector-Induced Toxicity. J. Virol. 76: 5711-5719 [Abstract] [Full Text]  
  • Xiang, Z., Gao, G., Reyes-Sandoval, A., Cohen, C. J., Li, Y., Bergelson, J. M., Wilson, J. M., Ertl, H. C. J. (2002). Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product. J. Virol. 76: 2667-2675 [Abstract] [Full Text]  
  • Cohen, C. J., Xiang, Z. Q., Gao, G.-P., Ertl, H. C. J., Wilson, J. M., Bergelson, J. M. (2002). Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor. J. Gen. Virol. 83: 151-155 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»